pancreatic cancer
Conditions
Sponsors
-
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Histologically or cytologically confirmed adenocarcinoma, adenocarcinoma squamous carcinoma of pancreatic cancer. 2) Patients who confirmed unresectable locally advanced or borderline resectable pancreatic cancer 3) The longest diameter of tumor does not exceed 10 cm by CT image 4) No sign of direct tumor invasion into gastrointestinal tract 5) Age 20 years old or older 6) Performance Status:0-1(ECOG) 7) No past history of surgery or chemotherapy for pancreatic cancer 8) No past history of radiation therapy to the abdomen 9) Sufficient organ functions
Exclusion criteria
Exclusion criteria: 1) Synchronous multiple cancers 2) Infectious disease to be treated 3) Past history of systemic steroid therapy (>10 mg/body of prednisolone) within 14 days 4) Active peptic ulcer 5) Interstitial pneumonia, pulmonary fibrosis, or inflammatory lung disease confirmed by medical history or imaging test 6) Pleural, pericardial, or abdominal effusion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| efficacy Overall Survival | — |
Secondary
| Measure | Time frame |
|---|---|
| efficacy Progression Free Survival, Response rate etc safety Incidence of Adverse event, Incidence of Serious adverse event etc | — |
Countries
Japan
Contacts
Public ContactMasashi Kanai
Kansai Medical University Hospital
Outcome results
None listed